The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis. [electronic resource]
Producer: 20051025Description: 2069-71 p. digitalISSN:- 0041-1345
- Age Factors
- Aged
- Antibodies, Monoclonal -- economics
- Basiliximab
- Bayes Theorem
- Computer Simulation
- Cost-Benefit Analysis
- Diuresis
- Humans
- Immunosuppressive Agents -- economics
- Kidney Transplantation -- immunology
- Markov Chains
- Monte Carlo Method
- Recombinant Fusion Proteins -- economics
- Spain
- Treatment Outcome
- Uncertainty
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.